21ENGBIO Engineered orthogonal ribosomes for programmable protein modification

Lead Research Organisation: University of Bristol
Department Name: Biological Sciences

Abstract

Proteins are tiny nano-scale molecular machines that act as the workhorses of all living cells. They underpin crucial tasks spanning sensing and signalling, the coordination of metabolism and even the self-assembly of structural elements of the cell. Many of these functions can be tailored by the modification of the proteins involved, offering a way for a cell to diversity its behaviour. The broad applications of proteins in biological systems makes them an important target for engineering new forms of biology or harnessing biological components and functions in other areas like Material Science. Being able to synthesise and modify proteins on demand could unlock this huge potential.

In this project we aim to directly tackle this challenge by creating what is termed an "orthogonal ribosome" that can synthesise proteins in parallel to a cell's native process. Importantly, our orthogonal ribosomes will be engineered to include attachment points for secondary components that are able to modify the protein being synthesised. By synthesising our proteins with orthogonal machinery, we avoid modifying native cellular proteins in a detrimental way and thus have the freedom to modify our own in diverse ways. Furthermore, by switching the modifying attachment that is present, we can easily change the type of modification made, creating a platform for programmable protein synthesis and modification.

To achieve this ambitious goal, we will use newly developed experimental methods that can create vast numbers of orthogonal ribosome designs with different attachment points and assess the impact these have on the ability for the ribosome to effectively synthesise a protein. Those designs that work well will be selected and then modifying attachments precisely designed using computer models and simulation to have shapes that ensure the region involved in modification is perfectly positioned on the ribosome. Finally, we will combine the engineered orthogonal ribosomes and modifying attachments within living cells and test their ability to modifying a target protein such that it becomes localised to the edge of a cell when altered - a change we will be able to easily monitor using single-cell microscopy.

This project is an attempt to develop the new methods needed to engineer the complex biological process of protein synthesis through the "augmentation" of a native biomolecular machine - the ribosome. Our flexible and modular approach using "plug-n-play" components offers the ability to rapidly alter the modifications made to a target protein without the need to build a new system from scratch, and opens opportunities for Biologists, Biological Engineers, and Material Scientists to better understand the function of proteins in their native context, precisely engineer their properties in living cells, and make use of highly modified proteins as nanoscale building blocks for new forms of sustainable, high-performance material. More broadly, our methodology also offers a path to harnessing other core cellular processes and repurposing their functionalities for novel applications in the emerging area of Engineering Biology.

Technical Summary

Proteins act as both molecular machines and physical building blocks of living cells and carry out a wide variety of functions. Modification of proteins further diversifies their functionalities. Thus, the ability to synthesise a target protein with programmable modifications would open avenues to better understand fundamental biological processes, as well as act as a substrate with which to build future biotechnologies and protein-based biomaterials in Engineering Biology.

As a step towards this goal, this project will develop a flexible platform for the production and targeted modification of proteins in living cells. To avoid potentially detrimental interactions with native translational processes, we will use an orthogonal tethered ribosome (oRibo-T) that is able to translate messenger RNAs that are not recognised by the host cell. Our oRibo-T will be engineered have additional protein attachment sites introduced by transposase mutagenesis, and high-throughput cell sorting and sequencing used to screen for oRibo-T variants where the attachment site has minimal impact on protein translation efficiency. Then, using computational protein design, we will develop protein-based modifying attachments consisting of an attachment domain, linker and N-myristoyltransferase domain positioned at the exist tunnel of the ribosome to allow for myristoylation of the ribosome-nascent protein chain. Precise positioning will be achieved by using a modular protein linker whose geometry is rationally designed using computational modelling. Finally, we will bring together our engineered oRibo-Ts with their complementary modifying attachments in Escherichia coli cells, using a fluorescent reporter protein as a target whose localisation to the cell membrane is induced by myristoylation. Efficiency of protein modification will be assessed in vivo via single-cell fluorescence microscopy and further verified using mass spectrometry and fluorescence polarisation assays.
 
Description This award has been extremely successful in terms of numbers of outcomes and achievements in the short timeframe over which it ran. Our key achievements were focused in two main areas:

1. Engineering of orthogonal ribosomes with attachment points for protein modifying enzymes - More than 40 modified orthogonal ribosome variants have been created with single and multiple (up to 3) modification points in collaboration with Dr Eszter Csibra (Imperial College London) and the support of Bjarne Klopprogge from the University of Hamburg. These sites have been assessed for their impact on translation rate, with some variants showing improved protein translation compared to the wild-type orthogonal ribosome. This work is currently being written-up for publication (a pre-print has already been released) and we are exploring options for potential IP around our enhanced orthogonal ribosomes. These could have many practical applications such as improved visualisation of single-cell translation capacity and can help support the optimisation of sustainable bio-based production.

2. Development of protein modifier attachments with defined geometries - We have created a new software package able to design protein linkers with both defined geometry and structural dynamics using a set of modular protein building blocks. The accuracy of our approach has been tested against molecular dynamics simulations (the current gold standard) and we found good concordance in qualitative features of the linker dynamics, which will be sufficient to support more efficient protein design workflows. Protein linkers are used extensively when engineering biology and form a crucial design parameter in advanced molecular tools like CRISPR and it's variants for genome editing (e.g. PRIME editing). Our software has been packaged and a publication submitted to a journal for review. We expect this tool to help supplement the growing use of machine learning based models like Alpha-fold, enabling dynamical considerations during protein design.
Exploitation Route Looking forward, our collaborator Dr Csibra is exploring ways to refine and expand on the efforts to engineering ribosomes performed here as the basis for independent Fellowship applications and Faculty applications to establish her own research group. In tandem, Gorochowski and Parmegianni are considering ways to continue development of the protein linker design approach pioneered in this grant - focusing on the ability for our method to capture and efficiently design structural dynamics. This effort will be led by Parmegianni and take the form of a responsive mode grant once the publication covering the developed software tool is published (submission to Nature Communications is in progress). This new grant will have the goal of building on existing modular protein design work as part of Parmegianni's EPSRC Early Career Fellowship (EP/S017542/1). Gorochowski will also be exploring how this methodology can be extended to augmenting the functionality of other molecular machines and has already begun to explore this area in regards to creating Cas enzymes and RNA polymerases with augmented functionalities through existing PhD projects in his lab. Finally, public release of the software we have created for the design of protein dynamics will open up new avenues for the biomolecular design community internationally.
Sectors Digital/Communication/Information Technologies (including Software)

Manufacturing

including Industrial Biotechology

Other

 
Description We have been approached by several companies in regards to the engineered orthogonal ribosomes we have generated. These are of interest due to their increased translation efficiency, which would be valuable for biotechnology companies using cells for protein production. We also have had interest from protein design start-ups regarding the software we have recently released for modelling protein dynamics. Our tool will enable more accurate predictions of de novo proteins and likely support more advanced protein based products.
First Year Of Impact 2024
Sector Manufacturing, including Industrial Biotechology
Impact Types Economic

 
Description New collaboration with Dr Csibra 
Organisation Imperial College London
Department Department of Bioengineering
Country United Kingdom 
Sector Academic/University 
PI Contribution We have shared constructed orthogonal ribosomes for testing across sites (Bristol and Imperial) and data from translation assays.
Collaborator Contribution Dr Csibra has provided input in the design of the orthogonal ribosomes, has constructed several specific designs her self, carried out testing of the orthogonal ribosomes and aided in the analysis of fluorescence data for molecular quantification.
Impact - Pre-print describing the design, construction and testing of our engineered orthogonal ribosomes for real-time monitoring in living cells.
Start Year 2022